Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ADAR1-mediated regulation of melanoma invasion.
Nemlich Y, Baruch EN, Besser MJ, Shoshan E, Bar-Eli M, Anafi L, Barshack I, Schachter J, Ortenberg R, Markel G. Nemlich Y, et al. Among authors: ortenberg r. Nat Commun. 2018 May 31;9(1):2154. doi: 10.1038/s41467-018-04600-2. Nat Commun. 2018. PMID: 29855470 Free PMC article.
Regulation of cancer aggressive features in melanoma cells by microRNAs.
Greenberg E, Hershkovitz L, Itzhaki O, Hajdu S, Nemlich Y, Ortenberg R, Gefen N, Edry L, Modai S, Keisari Y, Besser MJ, Schachter J, Shomron N, Markel G. Greenberg E, et al. Among authors: ortenberg r. PLoS One. 2011 Apr 25;6(4):e18936. doi: 10.1371/journal.pone.0018936. PLoS One. 2011. PMID: 21541354 Free PMC article.
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.
Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirsch J, Jacoby E, Eyal E, Rivkin L, Prieto VG, Chakravarti N, Duncan LM, Kallenberg DM, Galun E, Bennett DC, Amariglio N, Bar-Eli M, Schachter J, Rechavi G, Markel G. Nemlich Y, et al. Among authors: ortenberg r. J Clin Invest. 2013 Jun;123(6):2703-18. doi: 10.1172/JCI62980. J Clin Invest. 2013. PMID: 23728176 Free PMC article.
CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapy.
Sapoznik S, Ortenberg R, Galore-Haskel G, Kozlovski S, Levy D, Avivi C, Barshack I, Cohen CJ, Besser MJ, Schachter J, Markel G. Sapoznik S, et al. Among authors: ortenberg r. Cancer Immunol Immunother. 2012 Oct;61(10):1833-47. doi: 10.1007/s00262-012-1245-1. Epub 2012 Mar 24. Cancer Immunol Immunother. 2012. PMID: 22441657 Free PMC article.
Novel anti-melanoma immunotherapies: disarming tumor escape mechanisms.
Sapoznik S, Hammer O, Ortenberg R, Besser MJ, Ben-Moshe T, Schachter J, Markel G. Sapoznik S, et al. Among authors: ortenberg r. Clin Dev Immunol. 2012;2012:818214. doi: 10.1155/2012/818214. Epub 2012 Apr 23. Clin Dev Immunol. 2012. PMID: 22778766 Free PMC article. Review.
35 results